Search

Your search keyword '"B. Hügle"' showing total 37 results

Search Constraints

Start Over You searched for: Author "B. Hügle" Remove constraint Author: "B. Hügle" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
37 results on '"B. Hügle"'

Search Results

1. IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)

2. Protokolle zur Klassifikation, Überwachung und Therapie in der Kinderrheumatologie (PRO-KIND): Chronisch nicht-bakterielle Osteomyelitis (CNO)

Catalog

Books, media, physical & digital resources

3. Plasminogen deficiency

4. A constitutive nucleolar protein identified as a member of the nucleoplasmin family

5. The 22 S cylinder particles of Xenopus laevis. I. Biochemical and electron microscopic characterization

6. The 22 S cylinder particles of Xenopus laevis. II. Immunological characterization and localization of their proteins in tissues and cultured cells

7. Duration of effect in treatment of methotrexate intolerance in juvenile idiopathic arthritis using Eye Movement Desensitization and Reprocessing (EMDR) can be improved by Bi-lateral Alternating Stimulation Tactile (BLAST) wristbands.

8. α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis.

9. Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients.

10. Controversial Aspects of Diagnostics and Therapy of Arthritis of the Temporomandibular Joint in Rheumatoid and Juvenile Idiopathic Arthritis-An Analysis of Evidence- and Consensus-Based Recommendations Based on an Interdisciplinary Guideline Project.

11. The Diagnosis and Treatment of Rheumatoid and Juvenile Idiopathic Arthritis of the Temporomandibular Joint.

12. Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication.

13. Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry.

14. Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry.

15. MTX intolerance in children and adolescents with juvenile idiopathic arthritis.

16. Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis.

17. Mutations in topoisomerase IIβ result in a B cell immunodeficiency.

18. Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis.

19. Successful use of secukinumab in a 4-year-old patient with deficiency of interleukin-36 antagonist.

20. IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry).

21. Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary results.

22. Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effect.

23. Education and employment in patients with juvenile idiopathic arthritis - a standardized comparison to the German general population.

24. Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis.

25. Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.

26. Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis.

27. Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control study.

28. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.

29. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.

30. Plasminogen deficiency.

31. Molecular and clinical spectrum of type I plasminogen deficiency: A series of 50 patients.

32. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection.

33. Localization of ribosomal protein S1 in the granular component of the interphase nucleolus and its distribution during mitosis.

34. Drug-induced dispersal of transcribed rRNA genes and transcriptional products: immunolocalization and silver staining of different nucleolar components in rat cells treated with 5,6-dichloro-beta-D-ribofuranosylbenzimidazole.

35. Nucleolar changes after microinjection of antibodies to RNA polymerase I into the nucleus of mammalian cells.

36. A constitutive nucleolar protein identified as a member of the nucleoplasmin family.

37. Inhibition of nucleolar reformation after microinjection of antibodies to RNA polymerase I into mitotic cells.